Tag Archives: Point-of-Care Molecular Diagnostics Market to Become $5.6 Billion by 2030

Global Point-of-Care Molecular Diagnostics Market to Become $5.6 Billion by 2030

The point-of-care (POC) diagnostics are medical devices used to get an immediate result in the investigation (diagnosis & monitoring) of various diseases, such as cancer, diabetes, cardiac diseases, and others. However, Molecular diagnostics involves taking DNA or RNA, the unique genetic code found in our cells, and analyzing the sequences for red flags that can […]